US · Healthcare

Bio Path Holdings Inc (BPTH)

Biotechnology

Bio Path Holdings Inc (BPTH) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for BPTH

P/E ratio

18.00

Bio Path Holdings Inc (BPTH) — FAQ

What is BPTH's P/E ratio?

The price-to-earnings (P/E) ratio for Bio Path Holdings Inc (BPTH) is 18.00 (data as of 2026-03-23).

Does Bio Path Holdings Inc pay a dividend?

Dividend yield is not available in the current snapshot for Bio Path Holdings Inc (BPTH). Check the MyAverix Finance app for the latest dividend data.

What sector is Bio Path Holdings Inc in?

Bio Path Holdings Inc (BPTH) is classified in the Healthcare sector (Biotechnology industry).

What exchange is BPTH listed on?

BPTH is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)